NDC Pharmacologic Class N0000175823 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
54092-700 | Elaprase | Idursulfase | Solution, Concentrate | Intravenous | Takeda Pharmaceuticals America, Inc. | Human Prescription Drug |
58468-0070 | Aldurazyme | Laronidase | Injection, Solution, Concentrate | Intravenous | Genzyme Corporation | Human Prescription Drug |
68135-020 | Naglazyme | Galsulfase | Solution | Intravenous | Biomarin Pharmaceutical Inc. | Human Prescription Drug |
68135-100 | Vimizim | Elosulfase Alfa | Injection, Solution, Concentrate | Intravenous | Biomarin Pharmaceutical Inc. | Human Prescription Drug |
There are 4 NDC products with the pharmacologic class Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC].